Cargando…
Ensuring fair, safe, and interpretable artificial intelligence-based prediction tools in a real-world oncological setting
BACKGROUND: Cancer patients often experience treatment-related symptoms which, if uncontrolled, may require emergency department admission. We developed models identifying breast or genitourinary cancer patients at the risk of attending emergency department (ED) within 30-days and demonstrated the d...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287624/ https://www.ncbi.nlm.nih.gov/pubmed/37349541 http://dx.doi.org/10.1038/s43856-023-00317-6 |
_version_ | 1785061911592697856 |
---|---|
author | George, Renee Ellis, Benjamin West, Andrew Graff, Alex Weaver, Stephen Abramowski, Michelle Brown, Katelin Kerr, Lauren Lu, Sheng-Chieh Swisher, Christine Sidey-Gibbons, Chris |
author_facet | George, Renee Ellis, Benjamin West, Andrew Graff, Alex Weaver, Stephen Abramowski, Michelle Brown, Katelin Kerr, Lauren Lu, Sheng-Chieh Swisher, Christine Sidey-Gibbons, Chris |
author_sort | George, Renee |
collection | PubMed |
description | BACKGROUND: Cancer patients often experience treatment-related symptoms which, if uncontrolled, may require emergency department admission. We developed models identifying breast or genitourinary cancer patients at the risk of attending emergency department (ED) within 30-days and demonstrated the development, validation, and proactive approach to in-production monitoring of an artificial intelligence-based predictive model during a 3-month simulated deployment at a cancer hospital in the United States. METHODS: We used routinely-collected electronic health record data to develop our predictive models. We evaluated models including a variational autoencoder k-nearest neighbors algorithm (VAE-kNN) and model behaviors with a sample containing 84,138 observations from 28,369 patients. We assessed the model during a 77-day production period exposure to live data using a proactively monitoring process with predefined metrics. RESULTS: Performance of the VAE-kNN algorithm is exceptional (Area under the receiver-operating characteristics, AUC = 0.80) and remains stable across demographic and disease groups over the production period (AUC 0.74–0.82). We can detect issues in data feeds using our monitoring process to create immediate insights into future model performance. CONCLUSIONS: Our algorithm demonstrates exceptional performance at predicting risk of 30-day ED visits. We confirm that model outputs are equitable and stable over time using a proactive monitoring approach. |
format | Online Article Text |
id | pubmed-10287624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102876242023-06-24 Ensuring fair, safe, and interpretable artificial intelligence-based prediction tools in a real-world oncological setting George, Renee Ellis, Benjamin West, Andrew Graff, Alex Weaver, Stephen Abramowski, Michelle Brown, Katelin Kerr, Lauren Lu, Sheng-Chieh Swisher, Christine Sidey-Gibbons, Chris Commun Med (Lond) Article BACKGROUND: Cancer patients often experience treatment-related symptoms which, if uncontrolled, may require emergency department admission. We developed models identifying breast or genitourinary cancer patients at the risk of attending emergency department (ED) within 30-days and demonstrated the development, validation, and proactive approach to in-production monitoring of an artificial intelligence-based predictive model during a 3-month simulated deployment at a cancer hospital in the United States. METHODS: We used routinely-collected electronic health record data to develop our predictive models. We evaluated models including a variational autoencoder k-nearest neighbors algorithm (VAE-kNN) and model behaviors with a sample containing 84,138 observations from 28,369 patients. We assessed the model during a 77-day production period exposure to live data using a proactively monitoring process with predefined metrics. RESULTS: Performance of the VAE-kNN algorithm is exceptional (Area under the receiver-operating characteristics, AUC = 0.80) and remains stable across demographic and disease groups over the production period (AUC 0.74–0.82). We can detect issues in data feeds using our monitoring process to create immediate insights into future model performance. CONCLUSIONS: Our algorithm demonstrates exceptional performance at predicting risk of 30-day ED visits. We confirm that model outputs are equitable and stable over time using a proactive monitoring approach. Nature Publishing Group UK 2023-06-22 /pmc/articles/PMC10287624/ /pubmed/37349541 http://dx.doi.org/10.1038/s43856-023-00317-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article George, Renee Ellis, Benjamin West, Andrew Graff, Alex Weaver, Stephen Abramowski, Michelle Brown, Katelin Kerr, Lauren Lu, Sheng-Chieh Swisher, Christine Sidey-Gibbons, Chris Ensuring fair, safe, and interpretable artificial intelligence-based prediction tools in a real-world oncological setting |
title | Ensuring fair, safe, and interpretable artificial intelligence-based prediction tools in a real-world oncological setting |
title_full | Ensuring fair, safe, and interpretable artificial intelligence-based prediction tools in a real-world oncological setting |
title_fullStr | Ensuring fair, safe, and interpretable artificial intelligence-based prediction tools in a real-world oncological setting |
title_full_unstemmed | Ensuring fair, safe, and interpretable artificial intelligence-based prediction tools in a real-world oncological setting |
title_short | Ensuring fair, safe, and interpretable artificial intelligence-based prediction tools in a real-world oncological setting |
title_sort | ensuring fair, safe, and interpretable artificial intelligence-based prediction tools in a real-world oncological setting |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287624/ https://www.ncbi.nlm.nih.gov/pubmed/37349541 http://dx.doi.org/10.1038/s43856-023-00317-6 |
work_keys_str_mv | AT georgerenee ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT ellisbenjamin ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT westandrew ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT graffalex ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT weaverstephen ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT abramowskimichelle ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT brownkatelin ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT kerrlauren ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT lushengchieh ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT swisherchristine ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting AT sideygibbonschris ensuringfairsafeandinterpretableartificialintelligencebasedpredictiontoolsinarealworldoncologicalsetting |